Related Experiment Video
Updated: Aug 2, 2026

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
Published on: July 16, 2011
An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in
M Baiocchi1, I Marcucci, S Rose-John
1Istituto Ricerca Cesare Serono S.p.A, Via di Valle Caia 22, 00040, Ardea, (RM), Italy. mbaiocchi@uniroma1.it
Abstract:
H-IL-6 is a hybrid protein constructed to contain IL-6 and its soluble receptor linked by a flexible peptide chain. Here we show that H-IL-6 strongly enhances proliferation of human CD34(+)cells in serum-free liquid culture, and that the majority of the cells generated belong to the erythroid lineage, being positive for the marker Glycophorin A. Conversely, H-IL-6 does not increase the number of myeloid, CD13-positive cells. Comparable effects are observed on progenitors from cord blood and adult peripheral blood. Therefore, H-IL-6 triggers an erythroid-inducing signal in haematopoietic progenitor cells, independently from erythropoietin (EPO).
More Related Videos
Related Concept Videos
Lineage Commitment
Erythropoiesis
Regulation of Hematopoietic Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

